MMP9 and frontotemporal dementia: Further studies are necessary to fully elucidate the precise mechanisms and explore potential combination therapies that could enhance the efficacy of regorafenib, such as combining it with antibodies against MMP-9 like andecaliximab [28,29] or FTD/TPI.